Skip to content

Cannabis research published in 2020

Page 3 of 5: studies 41 to 60 of 92, newest first. Back to the cannabis overview

Studies

Escalating low-dose Δ9 -tetrahydrocannabinol exposure during adolescence induces differential behavioral and neurochemical effects in male and female adult rats.

European Journal of Neuroscience July 2020 Nafsika Poulia, Foteini Delis, Charalampos Brakatselos et al.

Cannabinoid administration during adolescence affects various physiological processes, such as motor and affective response, cognitive-related functions and modulates neurotransmitter activity. Literature remains scant concerning the parallel examination of the effects of adolescent escalating low-dose Δ9 -tetrahydrocannabinol (Δ9 -THC) on the behavioral and plasticity profile of adult rats in...

DOI: 10.1111/ejn.14598 (opens in new tab) Full text (opens in new tab) Adult Behavioral analysis Cannabinoids Neuronal plasticity

Who Turns to Amazonian Medicine for Treatment of Substance Use Disorder? Patient Characteristics at the Takiwasi Addiction Treatment Center

Journal of Studies on Alcohol and Drugs July 1, 2020 Ilana Berlowitz, Heinrich Walt, Christian Ghasarian et al. 19 citations

Our results suggest that the Amazonian medicine-based therapy attracts a diverse patient group not limited to regional residents and may be particularly appealing to more impaired SUD patients with a history of unsuccessful treatment. The sample's cultural diversity suggests an existing interest in such therapies among international SUD treatment-seeking patients. These findings are relevant in...

Distinguishing between cannabis-induced psychotic disorder and psychotic disorder with concurrent cannabis use: a diagnostic challenge

Romanian Journal of Psychiatry & Psychotherapy June 30, 2020 Cristiana Ţăpoi 1 citation

Approximately one-third of patients presenting with a first episode of psychosis have a history of cannabis use. Some of these patients meet the criteria for cannabis-induced psychotic disorder (CIPD), which is regarded as a disorder with better outcomes compared to other psychotic disorders. The aim of this paper was to determine whether there are differences in clinical and demographic...

DOI: 10.37897/rjpp.2020.2.2 (opens in new tab) Cannabis Derealization Psychosis Depersonalization +6

Cannabis and the developing brain challenge risk perception.

Journal of Clinical Investigation June 22, 2020 Y. Hurd

The past decade has seen a reduction in society’s perception of cannabis being of any risk or harm. However, we are in a transformational time in which cannabis’ health implications related to neurodevelopment, particularly for vulnerable populations, must challenge such perceptions of harmlessness. The combination of multiple interrelated factors — societal, political, and business — have...

Management of psychosis in the context of cannabis use: Beyond the chicken or the egg question

Paediatrics & Child Health June 1, 2020 Clairélaine Ouellet-Plamondon, Simon Dubreucq, Didier Jutras-Aswad 2 citations

A 17-year-old male is brought to the emergency room by a friend who finds him strange lately. The patient is very anxious and seems to be scared. He reports having recently discovered that government was spying on him, using a complex network of cameras and satellites. He has unplugged all of his house hold electronic devices and refuses to talk to his friend on the phone. During the interview,...

[Cannabis: Similarities and differences with tobacco].

Revue des maladies respiratoires June 1, 2020 P Mura, M Underner, B Brunet

Nicotine is the specific psychoactive substance of tobacco while tetrahydrocannabinol (THC) is the specific component of cannabis. The inhalation technique of cannabis is different from that of tobacco smoking: the volume of puffs is larger, inhalation is deeper, and pulmonary retention time is longer. Cannabis addiction is difficult to evaluate, both products often being smoked concomitantly....

1239 Mind Blown: Exploding Head Syndrome as a Side Effect of Marijuana

May 27, 2020 Christopher Missak, Jenie George, I. Gurubhagavatula

Marijuana use is increasing the United States and has been associated with increased sensory perception, euphoria, and altered cognition. Exploding head syndrome is a parasomnia characterized by loud explosion-like noises occurring prior to or during sleep. This the first report to link marijuana use with the occurrence of EHS. A 45-year-old man with depression, anxiety and multisubstance abuse...

M90. CANNABIS USE, CIGARETTE SMOKING, AND PSYCHOTIC EXPERIENCES IN ADOLESCENCE AND DIAGNOSIS OF PSYCHOSIS IN EARLY ADULTHOOD. A BIRTH-COHORT STUDY

Schizophrenia Bulletin May 18, 2020 Teemu Peltonen, Antti Mustonen, Jari Koskela et al.

Abstract Background Recent studies indicate that adolescent cannabis use (1) and cigarette smoking (2) increase the risk for psychosis. However, less is known about symptom profile associated with cannabis use and cigarette smoking prior to the psychotic episodes. Our aim was to study the associations between daily smoking, life-time cannabis use, and psychotic experiences in adolescence, and...

S96. EXAMINING DIFFERENCES BETWEEN CURRENT CANNABIS CONSUMPTION AND COGNITIVE FUNCTIONING OF FIRST-EPISODE PSYCHOSIS PATIENTS: A RETROSPECTIVE STUDY

Schizophrenia Bulletin May 18, 2020 Gabrielle Pochiet, Katie Lavigne, Ashok Malla et al.

Abstract Background Although growing research has observed a positive association between cannabis consumption and cognition in patients with first-episode psychosis (FEP), such better performance has not always been found across all cognitive domains. Furthermore, it remains unclear whether frequency of use is related to cognitive functioning in a dose-dependent manner. Understanding these...

Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition

Frontiers in Psychology May 14, 2020 Marco Colizzi, Mirella Ruggeri, Sagnik Bhattacharyya 50 citations

Research evidence suggests a dose-response relationship for the association between cannabis use and risk of psychosis. Such relationship seems to reflect not only an increased risk of psychosis as a function of frequent cannabis use, but also of high-potency cannabis use in terms of concentration of delta-9-tetrahydrocannabinol (∆9-THC), its main psychoactive component. This finding would be...

DOI: 10.3389/fpsyg.2020.00833 (opens in new tab) Cannabidiol Psychotomimetic Psychosis Hallucinogen +9

Cognitive mechanisms in cannabis-related paranoia; Initial testing and model proposal

Psychosis May 13, 2020 Katherine Newman‐Taylor, Thomas Richardson, Monica Sood et al. 18 citations

Cannabis use can increase severity of symptoms and risk of relapse for people with psychosis. Childhood sexual abuse and high schizotypy increase the risk further. The mechanisms involved remain unclear, and this limits psychological therapies. In three linked studies, we examined the role of two candidate mechanisms – external attribution and cognitive fusion. Study 1 examined these processes...

Do AKT1, COMT and FAAH influence reports of acute cannabis intoxication experiences in patients with first episode psychosis, controls and young adult cannabis users?

Translational Psychiatry May 12, 2020 Chandni Hindocha, Diego Quattrone, Tom P. Freeman et al.

Epidemiological and biological evidence support the association between heavy cannabis use and psychosis. However, it is unclear which cannabis users are susceptible to its psychotogenic effect. Therefore, understanding genetic factors contributing to this relationship might prove an important strategy to identify the mechanisms underlying cannabis-associated psychotic experiences. We aimed to...

The Relationship between Cannabis Use and Cognition in People with Bipolar Disorder: A Systematic Scoping Review

medRxiv April 29, 2020 T. Jordan Walter, Nina Pocuca, Jared W Young et al. 1 citation preprint

ABSTRACT Bipolar disorder (BD) and cannabis use are highly comorbid and are each associated with cognitive impairment. It is therefore important to understand the relationship between cannabis use and cognition in people with BD, as cannabis use in BD may be associated with greater cognitive impairment. We performed a scoping review to determine how much and what is currently known in this...

Acute effects of cannabis on speech illusions and psychotic-like symptoms: two studies testing the moderating effects of cannabidiol and adolescence

Psychological Medicine April 28, 2020 Claire Mokrysz, Natacha D. C. Shaban, Tom P. Freeman et al. 24 citations

BACKGROUND: Acute cannabis administration can produce transient psychotic-like effects in healthy individuals. However, the mechanisms through which this occurs and which factors predict vulnerability remain unclear. We investigate whether cannabis inhalation leads to psychotic-like symptoms and speech illusion; and whether cannabidiol (CBD) blunts such effects (study 1) and adolescence...

Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis

Translational Psychiatry April 21, 2020 Musa Sami, Amanda Worker, Marco Colizzi et al.

AbstractThe associative striatum, an established substrate in psychosis, receives widespread glutamatergic projections. We sought to see if glutamatergic indices are altered between early psychosis patients with and without a history of cannabis use and characterise the relationship to grey matter. 92 participants were scanned: Early Psychosis with a history of cannabis use (EPC = 29); Early...

Impact of Two-Weeks of Monitored Abstinence on Cognition in Adolescent and Young Adult Cannabis Users

Journal of the International Neuropsychological Society April 20, 2020 Alexander L. Wallace, Natasha E Wade, Krista M. Lisdahl

Abstract Objectives: Previous research suggests recovery from cannabis-related deficits in verbal learning and memory functioning after periods of cannabis abstinence in adolescents. Here, we examine how cannabis cessation affects cognitive performance over 2 weeks of monitored abstinence compared to controls in adolescents and young adults. Methods: Seventy-four participants (35 cannabis...

Cannabis and the Developing Adolescent Brain

Current Treatment Options in Psychiatry April 18, 2020 Adina S. Fischer, S. Tapert, Dexter Lee Louie et al.

Purpose of review This review summarizes (1) recent trends in delta-9-tetrahydrocannabionol [THC] and cannabidiol (CBD) content in cannabis products, (2) mechanism of action of THC and CBD and the neurobiological correlates of cannabis use on the developing adolescent brain, (3) effects of cannabis on psychiatric symptoms and daily functioning in youth (i.e., academic performance, cognition,...

Will Legalization and Commercialization of Cannabis Use Increase the Incidence and Prevalence of Psychosis?

JAMA Psychiatry April 8, 2020 R. Murray, W. Hall

There is a worldwide trend toward liberalizing cannabis policy and commercializing its sale. Uruguay legalized recreational cannabis in 2013, as did Canada in 2018, as well as 10 US states.1 Other countries have decriminalized the drug. In Holland, cannabis can be bought in designated cafes, and in Portugal, the police refer those who regularly use cannabis for counseling. Psychiatrists have...

Altered Signaling in CB1R-5-HT2AR Heteromers in Olfactory Neuroepithelium Cells of Schizophrenia Patients is Modulated by Cannabis Use.

Schizophrenia Bulletin April 6, 2020 D. Guinart, Estefanía Moreno, Liliana Galindo et al.

Schizophrenia (SCZ) has been associated with serotonergic and endocannabinoid systems dysregulation, but difficulty in obtaining in vivo neurological tissue has limited its exploration. We investigated CB1R-5-HT2AR heteromer expression and functionality via intracellular pERK and cAMP quantification in olfactory neuroepithelium (ON) cells of SCZ patients non-cannabis users (SCZ/nc), and...

Does cannabis use predict psychometric schizotypy via aberrant salience?

Schizophrenia Research April 6, 2020 Colm O’Tuathaigh, Christopher Dawes, Andrea Bickerdike et al. 13 citations

Cannabis can induce acute psychotic symptoms in healthy individuals and exacerbate pre-existing psychotic symptoms in patients with schizophrenia. Inappropriate salience allocation is hypothesised to be central to the association between dopamine dysregulation and psychotic symptoms. This study examined whether cannabis use is associated with self-reported salience dysfunction and schizotypal...

DOI: 10.1016/j.schres.2020.03.021 (opens in new tab) Cannabis Schizotypy Schizotypal personality disorder Clinical psychology +6